We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
An update on chronic obstructive pulmonary disease.
- Authors
Schellack, Natalie; Schellack, Gustav; Omoding, Richard
- Abstract
Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide. It is a chronic condition which affects the respiratory system and worsens over time. Cigarette smoking and advancing age are the two major risks associated with this disease. It is concerning that the global incidence of this chronic illness is on the rise. Current projections indicate that it will become the third leading cause of death by the year 2020. Inflammatory changes underlie the pathophysiology of COPD. Irreversible damage and progressive narrowing of the air passages follow. COPD is characterised by the progressive loss of lung function. In addition, the Global Initiative for Chronic Obstructive Lung Disease released the latest update on its global strategy for the diagnosis, management, and prevention of COPD in 2015. This article provides an overview of the causative risk factors, underlying disease process, pathophysiological changes, and the classification and management of COPD, including the latest perspectives on this highly prevalent condition.
- Subjects
CHRONIC bronchitis; OBSTRUCTIVE lung diseases; PULMONARY emphysema; ADRENERGIC beta agonists; MUSCARINIC antagonists; METHYLXANTHINES
- Publication
SA Pharmaceutical Journal Incorporating Pharmacy Management, 2017, Vol 84, Issue 3, p28
- ISSN
2221-5875
- Publication type
Article